|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/30 | (2006.01) |
| A61K2039/505 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K 16/30 | (2013.01) | ||
| C07K 16/40 | (2006.01) | ||
| C07K2317/21 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K2317/77 | (2013.01) | ||
| A61K 47/68 | (2017.01) | ||
| C07K2317/92 | (2013.01) | ||
| C07K2317/34 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| C07K 16/40 | (2013.01) | ||
| A61K 47/6871 | (2017.08) | ||
| A61K 47/6803 | (2017.08) |
| (11) | Number of the document | 3520816 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19153014.6 |
| Date of filing the European patent application | 2010-10-22 | |
| (97) | Date of publication of the European application | 2019-08-07 |
| (45) | Date of publication and mention of the grant of the patent | 2022-08-31 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 25447409 P | 2009-10-23 | US |
| (72) |
NAM, Samuel, S. , US
GREENFIELD, Edward, A. , US
BABCOOK, John , CA
O'KEEFE, Theresa , US
QIN, Shixin , US
|
| (73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome,
Chuo-ku,, Osaka-shi, Osaka,
JP
Amgen British Columbia , 7990 Enterprise Street, Burnaby, BC V5A 1V7, CA |
| (54) | ANTI-GCC ANTIBODY MOLECULES AND RELATED COMPOSITIONS AND METHODS |
| ANTI-GCC ANTIBODY MOLECULES AND RELATED COMPOSITIONS AND METHODS |